|
Description: The overall goal of the proposed research is to develop, test, and seek FDA approval for the versaHSDI instrument: a novel fluorescence and reflectance spectroscopic cancer imaging device based on a versatile, modular design. The versaHSDI system will facilitate early detection of neoplasia in a variety of organs, through use of interchangeable imaging probe modules adapted to endoscopic and/or superficial detection needs. The initial focus of the versaHSDI effort will be to detect colorectal cancer with subsequent development targeting nonmelanoma skin cancer detection. Our approach and effort will leverage experience gained by developing Science & Technology International s hyperspectral diagnostic imaging (HSDI ) system for detecting cervical cancer.
|
|
| |
| Science & Technology International |
$4,120 |
|
For-Profit |
Honolulu,
HI
|
|
|
Citation
|
|
Source:
Appropriations Report Language - Conference
|
|
Reference:
108-622
|
|
Location:
Line 29, Page 256
|
Citation Excerpt: HSDI
|
|
